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Abstract  Toxoplasma gondii is a ubiquitous protozoan parasite that is estimated to infect one-third of the world’s 
human population causing a wide range spectrum of diseases. Reports on the prevalence of T. gondii infection 
among infertile females are scarce. This case-control study aimed to screen the infertile females and pregnant 
controls for Toxoplasma infection investigating a possible association with infertility. A total of 319 female 
infertility ladies and 103 pregnant controls were examined for the pres-ence of IgG and IgM antibodies against T. 
gondii by using enzyme-linked immunosorbent assay. Ages in infertile ladies (26.8 years ± 4.7) was comparable 
with that of the controls (26 years ± 5.3), (p > 0.05). The overall seroprevalence of T. gondii in this study was 
57.52%. Anti-T. gondii IgG antibodies indicating latent infection with T. gondii was found in 193 (61.85%) of 312 
infertile ladies and 44 (44%) of 100 controls. There was a highly significant difference between the 2 groups (p = 
0.002). Our results found an association between toxoplasmosis and infertility. This finding encourage both 
prompting health education to prevent Toxoplasma infection in female population especially in childbearing age and 
further investigation to elucidate the causative relation between T. gondii infection and female infertility. 
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1. Introduction 
Toxoplasma gondii is an obligate intracellular parasite, 
which affects a wide-range of mammals including human. 
Based on serological studies, T. gondii is one of the most 
prevalent protozoan parasites [1]. High prevalence of the 
infection have been reported among pregnant women and 
women of childbearing age from different foci in Latin 
America, parts of Eastern / Central Europe, the Middle 
East, parts of south-east Asia and Africa [2]. 
Human infection is acquired through ingestion of food 
or water contaminated with oocysts shed in the feces of 
cats and other felines or viable tissue cysts in undercooked 
or raw meat [3,4]. Most cases of toxoplasmosis are 
asymptomatic or mild and influenza-like, but 
immunocompromised patients often develop fulminating 
life-threatening symptoms as pneumonia and encephalitis 
[5,6]. Primary infection during pregnancy may cause 
spontaneous abortion or stillbirth. In utero infection may 
cause congenital toxoplasmosis with ocular and 
neurological manifestations. 
Previous research on laboratory animals reported that 
infection with T. gondii could be a cause of infertility in 
experimental animals [7,8]. No previous reports about the 
relation between T. gondii infection and female infertility 
although about 21% of abnormal embryos and 24.2% of 
miscarriages and stillbirths have been related to T. gondii 
infection [9,10]. Recently, Li et al. [11] recorded a 
relation between female infertility and toxoplasmosis in 
China, which raises the concern about the importance of 
toxoplasmosis in female fertility problems and encourage 
further research in this area. 
The aim of this study was to investigate Toxoplasma 
seropostivity rates in infertile females and pregnant 
controls in Dakhalia governorate, Egypt and to record if 
there is a relation between infection and female infertility. 
2. Subjects, Materials and Methods 
2.1. Study Design and Study Populations 
Through a case-control study design, we studied the 
association of infertility with infection with T. gondii in 
female infertility patients and control subjects in Dakhalia 
governorate, Egypt from May, 2012 to May, 2013. A total 
of 319 infertile female patients attending Gynaecology 
and Obstetrics department, Mansoura University, 
Dakhalia, Egypt were enrolled in this study. All females 
had been married for at least two years and were being 
treated for primary infertility. Chosen females experienced 
normal sexual life and did not have any contraceptive 
measures. All cases had basic investigations of infertility 
including hystero-salpingography, mid luteal serum 
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progesterone assay and semen analysis of the partner were 
free. 103 pregnant women attending Gynacology and 
Obstetrics department, Mansoura University, Mansoura, 
Egypt for antenatal care were included as control subjects. 
This study was approved by the Ethics Committee at 
Faculty of medicine, Mansoura University. The purpose 
and procedures of the study were explained to all 
participants and a written informed consent was obtained 
from all of them. 
2.2. Sample Collection 
Three ml of venous blood was drawn aseptically from 
both patients and control subjects. The sera were separated 
by centrifugation at 3000 rpm for 5 min then stored at 
−20°C till further use. 
2.3. Serological Testing 
Serum samples were screened for anti-T. gondii specific 
IgM antibodies using a commercial kit (Toxoplasma IgM 
ELISA, Calbiotech Inc., CA) to exclude acute 
toxoplasmosis. Negative IgM antibodies to Toxoplasma 
gondii were tested again using a commercial kit 
(Toxoplasma IgG ELISA, Calbiotech Inc., CA) for 
detection of for anti-T. gondii specific IgG antibodies. 
According to the manufacturer’s recommendations, serum 
samples were diluted and used for testing; each serum 
sample was tested in triplicates. Positive and negative 
controls were included in the kit. 
2.4. Statistical Analysis 
Data were analyzed using the SPSS 16.0 software 
package. A Chi-square test was used to analyze 
differences of T. gondii seroprevalence in the tested 
groups. A P value < 0.05 was considered statistically 
significant. 
3. Results 
Seven samples from female infertility cases and three 
samples from pregnant controls were excluded due to 
positive anti-T. gondii specific IgM antibodies indicating 
acute infection. The age of female enrolled in the study 
ranged from 20 to 39 years with the mean age of 26.8± 4.7 
and 26 ± 5.3 years for female infertility patients and 
pregnant controls respectively. The overall seropostivity 
rate of T. gondii in the present study was 57.52% (237 / 
412) in both cases and control groups. Antibodies (IgG) to 
T. gondii were found in 193 (61.85%) of 312 infertile 
female patients cases and 44 of 100 pregnant women 
(44%). There was a significant difference between the 2 
groups (P < 0.05), indicating a correlation between T. 
gondii infection and female infertility (Table 1). 
Table 1. Seroprevalence of Toxoplasma gondii infection in female infertility patients and pregnant females controls 
Group Number of cases Number of seropositive cases (%) Chi-square P value OR (CI) 
Sterile 312 193 (61.85) 9.89 0.002 2.06 (1.28-3.34) 
Pregnant 100 44 (44)    
Total 412 237 (57.52)    
The anti-T. gondii IgG antibodies detection was 
estimated within 4 age groups (20-24 y, 25-29 y, 30-34 y 
and 35-39 y). The percentage of seropositivity in the 
female infertility patients were 57.57%, 62.28%, 63.15% 
and 73.91% respectively, while it was 34%, 46.66%, 60% 
and 70% respectively in the control group (Table 2). There 
is no significant difference (p > 0.05) in seropostivity 
among these ages in both groups. 
Table 2. Age distribution of seroprevalence of toxoplasmosis in female infertility patients and pregnant women 
 Infertile females Pregnant females 
Age group 
(years) Total number of cases No. of positive for Anti-T. gondii IgG (%) Total number of cases 
No. of positive for 
Anti-T.gondii IgG (%) 
20-24 99 57 (57.57) 50 17 (34) 
25-29 114 71 (62.28) 30 14 (46.66) 
30-34 76 48 (63.15) 10 6 (60) 
35-39 23 17 (73.91) 10 7 (70) 
Total 312 193 (61.85) 100 44 (44) 
4. Discussion 
It is well documented that toxoplasmosis is of crucial 
importance due to cosmopolitan distribution and wide 
range of diseases it cause. It is known that toxoplasmosis 
has some unfavorable effects on the reproductive capacity 
of both men and women [5,12]. So, this case-control study 
was carried to estimate the seropostivity rate of 
Toxoplasma infection among infertile females. The overall 
detection rate of toxoplasmosis among Egyptian females 
in childbearing age was 57.52%, in our study in Dakhalia 
governorate. This result approximates other Egyptian 
study of Elsheikha et al. [13] which reported 59.6% 
seroprevalence of anti-T. gondii IgG antibodies among 
blood donors in Mansoura University Hospital, Dakahlia 
governorate, Egypt. This high prevalence is due to lake of 
health education and exposure to risk factors including 
contact with cats, agricultural activities, eating raw 
unwashed vegetables, drink insufficiently boiled milk, 
eating insufficiently cooked meat like luncheon and 
shawerma [13,14]. 
These findings of the regional prevalence of T. gondii 
seropostivity was higher than those detected by other 
studies including Turkey [15], Malaysia [16], Chile [17], 
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India [18], Saudi Arabia [19], Mali [20] and northeast 
Thailand [21]. On the other hand, this result is less than 
the estimate of 69% and 79% among blood donors in 
southern Mexican state [22] and male blood donors in 
northeast Brazil [23] respectively. These variations in the 
prevalence of Toxoplasma among countries could be 
attributed to to geographic and temporal factors [24]. 
The prevalence of anti-T. gondii IgG antibodies among 
pregnant female was 44%, which is nearly similar to that 
of Alexandria governorate (46.2%) [25] and of El Fayoum 
Governorate (45.8%) [26] but lower than the percentage 
recorded in another Egyptian governorate, Menoufia, 
which was 67.5% [14]. This may be due to difference in 
sample size, test used for diagnosis, population 
characteristics of each governorates and their exposure to 
relevant risk factors. 
Our findings recorded a statistically significant higher 
prevalence (p < 0.01) of T. gondii infection in infertile 
female patients (61.85%) in Dakhalia governorate, Egypt 
in comparison with the control group, which may indicate 
a positive correlation between toxoplasmosis and 
infertility. Our findings are in agreement with those of Li, 
et al. [11] who reported a high prevalence (15.9%) of anti-
T. gondii IgG antibodies using ELISA among female 
infertility patients in comparison to 5.6% among 
pregnant–puerperant women. The hypothesized 
mechanisms for this positive correlation between 
infertility and chronic Toxoplasma infection include 
development of endometritis and fetal rejection due to 
local release of T. gondii from latently located cysts in 
endometrial tissue on stimulation during placenta 
formation [27], impaired folliculogenesis in ovaries, 
uterine atrophy and reproductive failure due to 
hypothalamic dysfunction as a result of chronic 
toxoplasmosis [28,29]. 
In our study, we found the prevalence of anti- T. gondii 
IgG antibodies in the older age group (30-39 years) was 
more than other age groups reporting 65.65% in female 
infertility patients and 65% in pregnant females. This 
result is consistent with a study carried in Menoufia 
governorate, Egypt among pregnant women reporting 
higher pprevalence of anti-T. gondii IgG antibodies in 
older ages than younger ages with a percentage of 88.4 
and 58.8 respectively [14]. This data on increasing 
Toxoplasma seropostivity with age correlate with the data 
reported by other authors [30,31]. It is logic that 
seropositive cases for toxoplasmosis increase with age as 
older ones have more chance to be exposed to parasite 
infection [32]. 
5. Conclusion 
In conclusion, this study revealed high seropostivity of 
IgG antibodies for toxoplasmosis among females in child 
bearing age in Dakhalia governorate, Egypt. Accordingly, 
the implementation of health education programs aimed to 
primary prevention of toxoplasmosis is mandatory. Also, 
the infertile females had a significant higher prevalence of 
T. gondii infection than the controls especially in older 
ages. These data highlight the possible correlation 
between Toxoplasma infection and infertility, however 
further studies are required to elucidate the mechanism of 
this association. 
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